Case reports on mistletoe therapy in neuroendocrine tumours

Case 1: Neuroendocrine tumour of the thymus

Case 2: Thyroid cancer

 

Last update: November 25th, 2021/AT1

Case 1: Neuroendocrine tumour of the thymus

Long-term survival of a patient with an inoperable thymic neuroendocrine tumour stage IIIa under sole treatment with Viscum album extracte: a CARE-compliant clinical case report

Reynel et al. 2020 [294]

A 54-year-old male patient from Peru, who suffered from constant fatigue, cough, shortness of breath and fever for several months, was diagnosed with a stage IIIa neuroendocrine tumour of the thymus, which was inoperable due to its size and severe invasiveness. Because the patient refused chemotherapy, he instead received subcutaneous mistletoe therapy alone three times a week for 85 months. The patient's quality of life improved significantly, allowing him to return to work, and no further tumour growth was noted for 71 months. Thereafter, progression occurred and the patient died 90 months after initial diagnosis.

 

Last update: November 25th, 2021/AT1

Case 2: Thyroid cancer

Treatment with Viscum album extract for thoracic ductal lesions after radical neck dissection: a case report

Kim et al. 2021 [312]

A 54-year-old woman was diagnosed with papillary cancer of the right thyroid lobe with metastasis in the cervical lymph nodes and consequently underwent total thyroidectomy and all lymph nodes localised in the neck were removed. Three days after surgery, thoracic duct injury was noted due to the leakage of bile from the Jackson-Pratt drain. Various medical and surgical treatments were performed without success, so that the mistletoe extract Helixor M was then injected through the drain. The injections stopped the leakage and the patient's condition improved without recurrence, so that the patient could be discharged on day 64 after surgery without further complications.

 

Last update: November 25th, 2021/AT1

Go to Heaven